Seraphim Space Investment Trust (SSIT) Q3 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2026 earnings summary
5 Oct, 2026Executive summary
Q3 to 31 March 2026: NAV rose 24.8% to £421.3m and portfolio value increased 30.7% to £433.3m, driven mainly by unrealised gains.
NAV per share increased to 177.63p from 142.30p; the quarter-end share price was 150.0p, up 25.0%.
Post-period milestones included HawkEye 360’s NYSE IPO, the conditional ALL.SPACE sale and a £136.5m C Share issue.
Financial highlights
Portfolio fair value increased to £433.3m from £331.6m; the reported unrealised fair-value gain was £101.7m, alongside £5.5m of FX gains and £0.7m of acquisitions.
Net assets rose to £421.3m from £337.5m; market capitalisation was £355.8m at quarter-end.
Liquid resources were £20.9m, or 5.0% of NAV; listed holdings could provide a further £4.1m of liquidity.
Q3 investment activity was £0.7m, comprising a follow-on investment in ALL.SPACE.
Outlook and guidance
73% of portfolio fair value was fully funded; 85% was fully funded or had at least 12 months of runway, while the unfunded private portfolio had 14 months’ average runway.
ICEYE forecast revenue above €1bn in 2027; its backlog conversion and further contract wins could support additional fair-value gains if comparable EV/revenue multiples remain stable.
The anticipated SpaceX IPO was viewed as a potential catalyst for investor interest and new capital into SpaceTech.
A pre-qualified pipeline of ~50 companies represented ~$1bn of potential investments, with around six opportunities actively progressing.
Latest events from Seraphim Space Investment Trust
- Portfolio value more than doubled as returns surged and post-period investment resumed.SSIT
H2 2026 - NAV rose 0.8%, with 72% of portfolio fair value funded for at least 12 months.SSIT
Q3 2024 - Fair value reached £201.5m; NAV rose to 96.18p, with six holdings targeting 2025 profitability.SSIT
H2 2024 - NAV fell 2.3%, while post-period FX lifted implied portfolio value to £208.2m.SSIT
Q1 2025 - NAV rose 5.1% as portfolio values improved, despite a 46.2% share-price discount.SSIT
H1 2025 - Portfolio value rose 3% as defence demand strengthened and AST sales boosted cash.SSIT
Q3 2025 - Portfolio fair value rose £58.3m as NAV per share gained 23.2%, led by ICEYE.SSIT
H2 2025 - Record NAV contrasts with a 40.8% discount as defense-led portfolio momentum builds.SSIT
Q1 2026 - NAV rose 20.1% as portfolio gains lifted fair value to £331.6m.SSIT
H1 2026